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ABSTRACT 
To determine the differences between prescribing a trial fitted 
versus a nomogram (System 1 0™) selected rigid gas permeable 
contact lens, 42 subjects were fit with one lens design on one eye 
and the other lens design on the opposite eye. Subjective 
responses for comfort and vision, objective signs of central 
corneal clouding, conjunctival injection, post keratometry 
readings, 3-9 staining, over refraction, post refraction and lens 
position were ranked and assigned to success levels for each eye. 
Subjects were evaluated at 1 week, 1 month, and 3 months. The 
first fit success rates were 92% for the trial fit and 86% for the 
nomogram fit. The trial fit lens attained significantly better 
outcomes in individual categories of comfort and over refraction. 
It was noted that the lens diameters differed significantly and a 
large percentage of both types of lenses benefited from a slight 
blend and edge modification. Although trial fitting remains the 
method of highest success, nomogram fitting (using System 1 0™) 
appears consistent enough to consider it an option for certain 
practice situations . 
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INTRODUCTION 
With the completion and success of the Operation Desert Storm 
campaign, acclaim for technological advances that aided in the 
Armed Services victory was heightened. One of these technological 
advances of interest to optometrists is the use of contact lenses 
by Army aviators. Army aviators in the Persian Gulf who wore 
contact lenses felt they performed better with contacts than with 
glasses. They cited better peripheral vision and reported they 
preferred their vision with contacts over glasses.1 These aviators 
wore disposable soft lenses ; however, rigid gas permeable (RGP) 
lenses were also available to them. 
In a study conducted on 620 Apache aviators who were fit with 
contact lenses, 90% of subjects were fit with soft disposable or 
flexible wear and 10% with RGP extended wear.2 Contact lenses 
are an authorized item of issue for some personnel in all three 
branches of service. Interest in contact lenses for military 
personnel has increased significantly due to the events in the 
Persian Gulf, and it is expected that even more personnel will be 
authorized to wear them while performing their official duties. 
Fitting techniques for RGP lenses would thus be of interest to a 
military optometrist who may encounter some unusual 
circumstances in his practice such as the need for expediency and 
lack of resources to provide traditional contact lens services. 
With the concern over soft lens problems during the mid to late 
80's and the introduction of new and better RGP lens materials, 
trends indicate that RGP fitting is on the rise.3 There is however a 
large group. of clinicians with the 'RGP avoidance syndrome' 
described b_y Schnider4 that may need to rediscover how to fit 
RGPs. These practitioners , and in fact all other practitioners, have 
a myriad, and at times intimidating array of prescribing methods 
from which to choose. 
The argument is held by some contact lens providers that in order 
to successfully prescribe a rigid gas permeable lens, trial fitting 
must be used to obtain a lens cornea relationship that will result 
in an optimum contact lens fit.5,6 In the Bennett et al. study, 
patients who were trial fitted had more confidence and motivation 
in the RGP fitting process than those who were not. 5 
6 
There are others who believe a lens can be fit successfully 
initially without trial fitting through the use of a fitting 
nomogram (e.g., providing refractive status, keratometry readings 
and lid aperture size to the laboratory or calculating lens 
parameters in office). In a survey of practitioners by Maruna et 
al.3, only 56% of respondents reported trial fitting a lens. Of the 
remaining 44%, 30% determined the lens parameters by calculation 
and 14% let the lab determine the lens parameters. Many 
practitioners feel they are too busy, have insufficient volume to 
justify a diagnostic fitting set, or do not want to hassle with rigid 
gas permeable lenses. Those desiring help with RGP fitting can 
find many companies providing contact lens fitting services to the 
eye practitioner utilizing refraction, corneal curvature and other 
ocular measurements. 
The answer to the question of whether there is a difference 
between trial fitting versus nomogram selections, could benefit a 
practitioner both in the military and civilian sector of optometric 
practice. 
METHODOLOGY 
Subjects 
Subjects were selected from the general population seeking care at 
the Pacific University Family Vision Center. Ages ranged from 16 
to 43 with a mean age of 29. There were 16 male and 21 female 
subjects. The distribution of gender and age groups are shown in 
Figure 1. Refractive errors ranged from plano to -8.25 diopters 
with refracfive astigmatism of less than 1.75 diopters. A 
complete optOmetric examination was conducted prior to 
consideration for the study. Eligible subjects had similar ocular 
characteristics between their two eyes (refractive power, corneal 
curvature) and needed to be free of ocular or systemic diseases 
which contraindicated rigid contact lens wear. A written informed 
consent was obtained from each subject prior to the study 
(enclosure 1 ). Subjects were either current soft lens wearers or 
persons having no history of contact lens wear within the last 6 
months. 
7 
l 
-, 
-I 
9 
8 
7 
a: 6 
w 5 m 
:E 4 :::;) 
z 3 
2 
1 
0 
1 6-2 0 
MEANAGE29 
21-25 2 6-30 31 -35 
AGE GROUPS 
l1mJ FEMALE 
BMALE 
36-40 41-45 
Figure 1: Age group ranges and gender distribution. 
Lenses 
The RGP lenses used in the study were of the fluorosilicone 
acrylate family (Fiuoroperm 30, Paragon Optical). Early 
assessments of the Fluoroperm 30 have been generally favorable. 
Lens stability is sufficiently managed by lens thickness and design . 
Reported advantages of the material appear physiologically and 
physically significant in the areas of oxygen permeability, 
cleanliness and comfort.?, 8 
Procedures 
Twenty-one · subjects were trial fitted by each investigator with a 
standard design RGP. The investigators were military 
optometrists with 1 0 years of contact lens fitting experience. 
Base curve, diameter and peripheral curves were tailored to each 
individual's eyes using Bennett's fitting guide to obtain optimal 
centration, movement and bearing characteristics.9 A pair of 
lenses were ordered according to the fitter's specifications from 
Valley Contax, Eugene, Oregon, who manufactured the lenses in the 
Fluoroperm 30 material. The requested ocular parameters 
(keratometry readings, spectacle refraction and aperture size) for 
the same patient were supplied to Lens Mode, Millburn, New Jersey, 
for their analysis. A pair of lenses from the Fluoroperm 30 
material were supplied according to Lens Mode's System 1 OTM 
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design that mathematically coordinates curvature, diameter and 
sagittal depth. Both pairs of lenses were inspected and verified 
upon receipt. Each investigator randomized one lens from each 
design to each eye of their subjects . The subjects were then 
turned over to the other investigator for follow up. Neither patient 
nor follow-up investigator was aware of which eye was wearing 
which design. 
Lenses were dispensed with appropriate lens care instructions for 
wear. All subjects started with the Alcon Soaclens System RGP 
starter kit without use of the enzyme tablets. Several subjects 
did require different systems due to allergic reactions to 
thimerosal. The enzymatic process was added to a few of the 
subject's cleaning regimens due to problems with protein build up. 
Evaluations were conducted following 1 week, 1 month and 3 
months of lens wear. Each visit included an evaluation of patient 
satisfaction, where subjects were asked to grade vision and 
comfort (enclosure 2). Contact lens performance was evaluated by 
fluorescein pattern, lens position, refractive status and anterior 
segment ocular health. Injection, central corneal clouding, 3-9 
desiccation, over refraction, post refraction changes, keratometry 
changes and lens position were used in the objective evaluation 
(enclosure 3). A five point grading scale was used for both 
subjective symptoms and objective signs. The scales were 
anchored descriptively; e.g ., where 1 was very comfortable--can't 
tell the lens is on, to 5 intolerable--not able to wear the lens for 
more than 1 hour. Modifications of the peripheral blends and edges 
were performed as indicated on both lens designs to improve 
comfort. 
Data Analysis · 
The investigator's professional judgment was used to determine 
the rankings in the grading scales. The data were ranked, summed 
and assigned to a success level. The success level was determined 
by the worst score across all variables (Table 1 ). For example, a 
subject could have a 1 in all categories, but if he/she had a 5 in 
comfort, they were considered a level 5, not successful. Some 
subjects could have one of two scores that were so similar that 
the investigators judged them to be essentially in the same level. 
For example, in the category of comfort, a subject could judge a 
lens to be a one, very comfortable, can't tell the lens is on, or a 
9 
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two, comfortable, occassional lens sensation. They were still 
considered a level one, very successful (See enclosure 2). Another 
example is the category of central corneal clouding. A rank of 4 
was central corneal clouding with distinct borders, area of 
clouding visible against iris in a dimly lighted room and a rank of 5 
was dense clouding, visible in normal room lighting(See enclosure 
3). Either rank in the investigators opinion would have indicated a 
fit at level 5, not successful. The data were entered in a database 
management package on the Macintosh computer and analyzed by 
non-parametric statistics for matched pairs (Wilcoxon signed-
ranks statistic and chi square). An alpha level of .05 was used to 
determine significance. 
Table 1: Assignment of scores to success levels (1=best, 
5=worst) 
LEVEL 1 LEVEL 2 LEVEL 3 LEVEL 4 LEVEL 5 
Category Very Successful Moderately Marginally Not 
Successful Successful Successful Successful 
Comfort 1, 2 3 3 4 5 
Vision 1, 2 3 3 4 5 
CCC 1 1 2 3 4, 5 
3-9 stain 1 1 2 3 4, 5 
Injection 1 2 2 3 4, 5 
OR 1, 2 2 3 4 5 
Post Ref. 1, 2 3 3 4 5 
K. changes 1, 2 2 3 4 5 
CL Pos. 1,2 2 3 4 5 
Note: The overall success level is determined by the combination of the worst ·scores -
across all vari~tbles. 
RESULTS 
Of the 42 patients enrolled, 37 completed the study and 5 patients 
were not able to tolerate RGP wear. Neither gender or age made a 
difference on the success or failure rates, thus these were not 
intervening variables that affected the data sets. 
In terms of subjective symptoms, subjects noticed that the trial 
fitted lens was significantly more comfortable at week 1, but no 
difference was noted at month 1 or month 3. The percentage of 
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lenses that needed edge rolling and /or blend modification to 
improve comfort was 30% for the trial lens and 41% for the System 
1 QTM lens. Subjects did not notice a significant difference in 
vision between the two fitting methods during all examining 
periods. 
The investigators noticed no difference in objective signs for any 
examining periods for central corneal clouding, injection, 3-9 
desiccation staining, keratometry findings, post refraction and 
lens position (Figure 2). 
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Figure 2: Nomogram {System 10™) lens right eye {top) and 
trial fit lens left eye (bottom). Notice that the 
positioning and edge lift are approximately the same 
between the two eyes. The black dot at the 6 o'clock 
position in the top picture indicates that it is the right 
lens. The blend of the left lens is more feathered in 
appearance than the right lens. Otherwise, can you tell a 
difference between the two fits? 
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Over refraction was significantly different between the two lens 
groups at week 1. The range of over refractions for the trial fit 
method was from -.25 to +.25 and from -.50 to + 1.00 for the 
System 1 0™ method (Table 2). 
Table 2: Over refraction range distribution and frequency. 
OVER REFRACTION TRIAL FIT SYSTEM 10™ 
c:x.ANT PERCENT COlNf PERCENT 
-1 . 0 0 0 0 
-0.75 0 0 
-0.50 0 6 16% 
-0.25 1 2 32% 7 19% 
0.00 22 60% 20 54% P=.04 
0.25 3 8% 1 3% 
0.50 0 2 5% 
0.75 0 0 
1.00 0 1 3% 
The correlation difference between calculated (theoretical) versus 
ordered . lens power of the trial fit method was .965 and System 
1 0™ method was .977 (P=.045). See figure 3 for differences 
between calculated and observed powers for the two methods. 
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Figure 3: The correlation of the difference between the 
calculated and ordered powers for the trial fit and System 
10™ lenses. 
Other Results 
The distribution of lens diameter ordered differed significantly 
between the two fitting groups with a chi square p value of .007. 
The distribution of lens diameters is illustrated in figure 4. 
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Figure 4: Diameter ranges for Trial Fit vs. System 1 0™. 
The "first fit" success rate for the trial fit method was 92% and 
86% for the System 1 0™ method. First fit success was defined as 
a subject who had attained a minimum of 8 hours of daily wear 
with acceptable subjective and objective findings. The subject 
could fall into any level, except level 5, according to the grading 
scales using the initial lens dispensed . 
The outcomes for all examining periods were significant, with the 
trial fit method ranking h·igher than the System 1 QTM method. (Table 
3) 
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Table 3: Outcome ranks for trial fit and System IOTM 
subjects. 
OUTCOMES 
FOLLOW UPS SUBJECTS HIGHER HIGHER TIES p 
WI FIRST RANKS RANKS FOR VALUE* 
FIT FOR TRIAL SYSTEM 
LENSES FITS 10™ 
WEEK 1 37 12 3 22 .o 1 
MONTH 1 35 1 3 4 18 • 0 4 
MONTH 3 33 12 1 20 . 0 2 
*WILCOXON SIGNED-RANK TEST 
DISCUSSION 
Contact lenses are essential to ametropic personnel who need to 
utilize technologically sophisticated equipment for which no 
optical correction device has been designed. This problem is 
magnified in urgent situations encountered in military actions. 
Military optometrists occasionally are faced with situations where 
time, expediency and/or remoteness dictates their clinical 
decisions. When RGPs are indicated, a contact lens fitting 
nomogram for RGPs with a high first fit success rate as the 
System 1 0™ could prove useful. The major differences between 
the two fitting methods should be kept in mind when considering 
how one will ultimately prescribe RGPs. 
The "first fit" -success rate was 92% for the trial fit versus 86% 
for System 1 0™. Although the percentage difference between the 
two fitting methods was minimal, the outcome findings which 
combined clinical data, both objective and subjective, were 
significant between both fitting methods for all examining periods 
as illustrated in Table 3. The major factors that seemed to 
influence the outcome in favor of the trial fit lenses were comfort 
and over refraction. 
The difference noticed in comfort between the two fitting methods 
could be attributed to several factors. The System 1 0™ lenses had 
a higher percentage of lenses that needed edge/blend modifications 
16 
(see Figure 2 for difference of blend design). Another factor may 
be a difference in the method of fabrication between the two 
laboratories. It is interesting to note that both laboratories had a 
fairly high percentage of lenses that benefited from modification. 
Most modifications were done at week 1 which may explain why 
comfort improved for month 1 and month 3. 
Comfort difference may also have been a function of lens diameter. 
The System 1 0™ design lenses tended to have smaller diameters 
than the trial fit lenses which may result initially in more lid 
sensation. Other factors affecting comfort may have been that 
some patients reported deficiencies in vision as 'comfort'. These 
patients were satisfied with the vision they obtained from each 
eye alone, but were not happy with the way they saw with both 
eyes (i.e., binocularity). This might explain why there was no 
significant difference noted in vision between the- two fitting 
methods even though a significant difference in over refraction 
existed. 
The significance in over refraction brought out a couple of 
interesting differences apparent between the two fitting methods. 
The over refraction results in Table 2 showed that the System 1 0™ 
lens values were more widely dispersed than the trial fit method. 
The lower correlation factor of observed versus expected values 
for lens power for the trial fit method or the System 1 0™ method 
was expected. We assumed that the System 1 0™ power 
calculations were based on theoretical models and therefore 
differences between the calculated and ordered powers would be 
closer to one. As illustrated by Figure 3, this appeared to be true 
and the differences between calculated and ordered powers for the 
trial lenses- were more widely dispersed. Both findings confirm 
that the comeal topography does not always fit theoretical models. 
In summary, trial fitting remains the method of choice for the best 
chance for RGP success. However, the use of nomograms such as 
the System 1 0™ should be a viable option to those practitioners 
with limited time, money and experience. If a practitioner is going 
to use a nomogram such as the System 1 0™, a more active role in 
selecting lens diameter might be helpful. A closer look at the 
peripheral curve design with the fluorescein pattern may also aid 
in increasing comfort of the lens. The refractive power of the 
contact lens may need to be fine tuned after dealing with a 
particular lab design and tailoring future orders to your 
17 
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satisfaction. Knowledge of basic lens modification would prove 
useful for any type of RGP fitting. Each practitioner has to decide 
what first fit success rate and clinical findings are acceptable for 
him/her when deciding how they are going to fit a RGP lens. If the 
choice of whether RGP's should be incorporated into a practice 
relies on the decision to use a nomogram, by all means just do it! 
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ENCLOSURE 1 
INFORMED CONSENT DOCUMENT 
Lens Mode System 10™ Clinical Trial 
Institution ; 
A. Title 
B. Principal Investigators 
C. Location 
D. Dates of project: 
1 . Description of project 
Trial fitting vs System 1 0™ fitting 
Joel T. Postma, OD (690-4591 H) 
Amy M. Postma, OD (357-6151 #2276 M, 
T, F, 224-2323 W, Th) 
Portland Family Vision Center 
Portland Medical Center 
511 SW 10th Ave 
Portland, Oregon 97205 (224-2323) 
January, 1991 to September, 1991 
This research project is designed to test the clinical performance of 
lenses fitted by traditional trial fitting methods compared to the System 1 0™ 
fitting method advocated by Lens Mode. Subjects will wear one lens fitted by 
each system and will be asked to compare the performance of each lens. 
Observations of on-eye lens performance and eye health will also be made by 
an optometrist over a 3 month period. 
2. Description of risks: 
All procedures performed in this study will be current, accepted clinical 
procedures for the fitting and management of contact lens patients. Unadapted 
rigid lens wearers may experience lens awareness during the adaptation 
period (20 minutes to 2 weeks). Small amounts of ocular redness and tearing 
may occur witti lens wear, and there is very small risk of ocular infection and/or 
loss of vision with the use of daily wear contact lenses. This risk increases with 
non-compliance to care and follow-up schedules. Subjects who do not comply 
with prescribed regimens will be discontinued from the study and will be 
required to forfeit their lenses or lose their contact lens deposit fee. All subjects 
will sign an informed consent document. 
3. Description of benefits : 
Subjects accepted for study participation will receive complimentary 
lenses and care products for the duration of the study (3 months). They will 
receive optometric services for one year under the annual contact lens service 
agreement for $80. This does not include contact lens care products (i.e. 
contact lens solutions) after the initial 3 months. Subjects who complete the 
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study will be entitled to keep their study lenses. Further services can be 
obtained from Pacific University as a regular clinic patient with standard tees. If 
you prefer a different practitioner, we will be happy to forward our data 
concerning the study upon your written request. 
4. Alternatives advantageous to subjects: 
Some subjects may be better suited to soft lens wear or spectacles. 
Subjects not able to successfully complete the study will be given a 25% 
reduction on spectacles, and/or soft lens material fees. If all contact lens wear is 
ceased, a refund of the annual care agreement fee will be given, according to 
the following schedule: 
Lens wear ceased at or before: 
1 week follow-up 
1 month follow-up 
3 month follow-up 
After 3 months of lens wear 
Refund amount 
$80 
$60 
$40 
none 
NOTE: No portion of the general examination fee will be refunded. Subjects 
who chose to continue in another type of contact lens will 1lQ1 receive a 
refund of the annual care agreement fee; however their services will be 
covered until their agreement expires. NO lens exchange privileges will 
be included for these subjects under this arrangement, except those 
covered by manufacturers' warranties. 
5. Confidentiality of records: 
Records of this project will be maintained in a confidential manner and 
no name-identifiable information will be released. 
6. Compensation and medical care : 
If you ~re injured in this study, it is possible that you will not receive 
compensation or· medical care from Pacific University, the investigators, or any 
organization associated with the project. All responsible care will be used to 
prevent injury, however. 
7. Offer to answer any inquiries: 
The investigators will be happy to answer any questions you may have at 
any time during the study. If you are not satisfied with the answers you receive, 
please call Dr. James Peterson at 357-0442. 
During your participation in this project, you are not a Pacific University 
clinic patient for contact lens care. All questions should be addressed to the 
study investigators, who will be solely responsible for any treatment (except for 
an emergency). It is imperative that you keep your scheduled appointments to 
ensure continuity of care and data collection by each investigator. 
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8. Freedom to withdraw: 
You are free to withdraw your consent and to discontinue participation in 
this project at any time without prejudice to you (see also section 4). 
I have read the above and understand its meaning. I am 18 years of age or 
over, or this form is signed for me by my parent or guardian 
Printed name ----------------------
Signed ----------------- Date -----
Address ---------------- Phone ___ _ 
City ------------- State ----- Zip __ _ 
Name and address of a person not living with you who will always know your 
address: 
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ENCLOSURE 2 
Subjective Grading Scales 
Comfort: 
1. Very comfortable - can't tell the lens is on. 
2. Comfortable - occasional lens sensation 
3. Acceptable - mild lens sensation approximately 50% of day 
4. Marginal - moderate lens sensation most of day 
5. Intolerable - not able to wear lens for more that one hour 
- Vision: 
1 . 
2. 
3. 
4. 
5. 
Great - can see much better than with glasses. 
Good - can see slightly better than glasses. 
Acceptable - can see as well as glasses. 
Marginal - see slightly worse than glasses. 
Unacceptable - see much worse than glasses. 
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ENCLOSURE 3 
Objective Grading Scales 
Central corneal clouding (C.C.C.) 
1. No C.C.C.,cornea clear. 
2. Just detectable corneal haze without distinct borders. 
3. Borders distinct but visible only against pupil background. 
light density. 
4. Borders very distinct. Area of clouding visible against iris 
and in dimly lighted room. 
5. Dense clouding. Visible in normal room lighting. 
Corneal three-and-nine desiccation staining (photos will be used to 
clarify grading) 
1. Not present. 
2. Diffuse punctate staining . 
3. Mild coalescence of staining . 
4. Moderate coalescence. 
5. Neovascularization and or opacification. 
Injection 
1 . Not present. 
2. Few conjunctival vessels dilated. 
3. Mild congestion and dilation of conjunctival vessels. 
4. Moderate congestion and dilation of conjunctival vessels. 
5. Entire bulbar conjunctiva injected. 
Over-refraction 
1 . Excellent Plano 
2. Good +.25 
3. Fair -.25-+.50 
4. Marginal -.50 
5. Unacceptable >+.75 
Post refraction changes after 15 minutes 
1. No change 
2. Good ±.25 
3. Fair ±.50 
4. Marginal ±.75 
5. Unacceptable ;:::±1.00 
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Keratometry changes 
1. Minimal change 0 - ±.25 
2. Good ± .. 50 - ±.75 
3. Fair ±.1.00 
4. Marginal ±.1.25 
5. Unacceptable ~±1.50 
Lens position 
1. Optimal - centers from 2-4 with no nasal or temporal 
decentration. 
2. Good - centers from 2-4 with slight nasal or temporal 
decentration. 
3. Acceptable - centers from 2-4 with moderate nasal or 
temporal decentration but full pupillary coverage. 
4. Marginal - centers from 1-2 or 4-5 with minimum 
pupillary coverage. 
5. Not acceptable - lens decenters on eye to degree that edge 
bisects the pupil. 
Outcome (see enclosure 3) 
1. Very successful 
2. Successful 
3. Moderately successful 
4. Marginally successful 
5. Unsuccessful 
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ENCLOSURE 4 
Outcome Criteria 
Level 1 (very successful) overall grading score (<16) 
comfort-grade 1 or 2 
vision-grade i or 2 
CCC-grade 1 
3-9 stain-grade 1 
Injection-grade 1 
OR-grade 1 or 2 
Post R-grade 1 or 2 
K's-grade 1 or 2 
Position-grade 1 or 2 
Level 2 (successful) overall grading score: (<20) 
comfort-grade 2 or 3 
vision-grade 1-3 
CCC-grade 1 
3-9 stain-grade 1 
Injection-grade 1 or 2 
OR-grade 1 or 2 
Post R-grade 1-3 
K's-grade 1 or 2 
Position-grade 1 or 2 
Level 3 (moderately successful) overall score (<25) 
comfort-grade 1-3 
vision-grade 1-3 
CCC-grade 1 or 2 
3-9 stain grade 1 or 2 
Injection-grade 1 or 2 
OR-grade 1- 3 
Post A-grade 1-3 
K's-grade 1-3 
Position-grade 1-3 
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Level 4 (marginally successful) overall score: (<34) 
comfort-grade 1-4 
vision-grade 1-4 
CCC-grade 1-3 
3-9 stain grade 1-3 
Injection-grade 1-3 
OR-grade 1-4 
Post A-grade 1-4 
K's-grade 1-4 
Position-grade 1-4 
Level 5 (unsuccessful) overall score: (>34) 
any category unacceptable or intolerable on the first fit lens. 
comfort grade 5 
vision grade 1-5 
CCC-grade 1-5 
3-9 stain grade 1-5 
Injection-grade 1-5 
OR-grade 1-5 
Post A-grade 1-5 
K's grade 1-5 
Position-grade 1-5 
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APPENDIX 1 
Di stri but ion of Gender end Si gnifi cence of P ess/F eil 
SEX 
Bar: Element: Count: Percent : 
I~ !MALE :FEMALE ~~~ 143.243 56 .757 
Gender Si gni fi cence for the Tri e 1 Lens 
DF: 
Total Chi-Square: 
G Statistic: 
Contingency Coefficient: 
Phi : 
Con-tingency Table Analysis 
Summary Statistics 
1 
2.162 
• 
.226 
.232 
Chi-Square with continuity correction : .736 
p=.1414 
p=.391 
Gender Si gnifi C!lnce for System 10 
DF: 
Total Chi-Square : 
G Statistic : 
Contin9ency Coefficient : 
Phi : 
Coniingen_cy Table Analysis 
Summary Statistics 
1 
.988 
1.072 
.152 
.153 
Chi-Square with continuity correction: .259 
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p=.3203 
p= .61 1 1 
!-Mode 
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APPENDIX 2 
Age Significance for Pass/Fail Rates for the Trial Fit 
Contingency Table Analysis 
Summary Statistics 
DF : 5 
Total Chi-Square: 2.042 p=.8433 
G Statistic: • 
Contingency Coefficient : .22 
Cramer's V: .226 
Age Significance for Pass/Feil Retes for System 10 
Contingency Table Analysis 
Summary Statistics 
DF: 5 
Total Chi-Square : 4 .194 p= .5219 
G Statistic: • 
Contingency Coefficient : .301 
Cramer's V: .316 
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APPENDIX 3 
Age Groups end Stetisticel Anelysis 
Age Groups 
B~r · From · (.~) To· ( <) Count· Percent: 
1 16 21 10 13.514 
2 21 26 18 24.324 
3 26 31 12 16.216 
4 ' 31 36 10 13 .514 
5 36 41 18 24.324 
6 41 46 6 8.108 
Stetisticel Anel!-tsis 
Me en Std. Dev . Std . Error Verience Coef. Ver. Count 
129.432 ,7.971 1.927 163.536 127.082 174 
Minimum Meximum Renge Sum Sum Squered Missing 
116 43 I 27 2178 168742 131 I 
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APPENDIX 4 
Diameter Chi Square and Frequency 
Summary Statistics 
DF : 7 
Total Chi-Square: 19.4 p=.007 
G Statistic : • 
Contingency Coefficient: .456 
Cramer's V: .512 
--
X1 : Trial - Diam 
Bar · From · (~) To · ( <) Count : Percent· 
1 8.4 - 8 .6 0 0 
2 8.6 8 .8 0 ,o 
3 8.8 9 4 1 0.811 
4 9 9.2 2 5.405 
5 9 .2 9.4 19 51 .35 1 -Mode 
6 9.4 9 .6 11 29.73 
7 9 .6 9 .8 1 2.703 
8 9.8 10 0 0 
X2: System 10- Diam 
Bar · From · ( 2) To·(<) Count· Percent· 
1 8.4 8 .6 1 2 .703 
-
2 8 .6 8 .8 5 13.514 
3 8.8 9 7 18.919 
4 9 9.2 8 21.622 -Mode 
5 9 .2 9.4 6 16.216 
6 9.4 9 .6 7 18.919 
7 9 .6 9 .8 2 5.405 
8 9.8 10 I 1 2.703 
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APPENDIX 5 
Over Refraction Significance and Rank Frequency at Week 1 
Yllcoxon signed-rank Trial - 'W1/0R System 10 - Yl/OR 
Number : }; Rank : Mean Rank: 
- Ranks ~1_7 _______ ~2_1_8_. 5 ______ ~1_2_. 8_5_3 ___ --1 
+ Ranks 7 81 .5 11 .643 
~------~-------~------~ 
note 13 cases eliminated for difference= 0. 
z -1 .957 p = .0503 
Z corrected for "ties -2.083 p = .0372 
# tied groups 2 
Renk Frequency for the Trial Lens 
Trial - Y1/0R 
Bar· From · (.~) To · ( <) Count· Percent· 
1 1 2 18 48.649% -Mode 
2 2 3 17 45.946% 
3 3 4 2 5.405% 
4 4 5 0 0% 
5 5 6 0 0% 
Rank Frequency for System 10 
System 10 - 't/1/0R 
Bar· From · (.~) To · (<) Count· Percent· 
l 1 2 12 32.4329iS 
2 2 3 20 54.0549iS -Mode 
3 3 4 1 2 .703% 
4 4 5 3 8 .1 089iS 
5 5 6 1 2.7039iS 
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APPENDIX 6 
Over Refraction Significance and Rank Frequency at Month 1 
'w'ilcoxon signed-rank Trial - Ml/OR Sys1em 10- Ml/OR 
Numbe-r : ~ Rank: Me-an Rank : 
-R4nks ~~1_2------------~~~71_37_3 ____________ 1~1_1_.0_8_3 ________ ~ + Ranks 8 9.625 
~------------~--------------~------------~ 
note 15 cases eliminate-d for difference= 0 . 
z -1 .045 p = .2959 
~ corrected for ties -1 .114 p = .2655 
# tied groups 3 
Note: 2 cases deleted w1th m1ssmg value-s. 
Remk Frequency for the Triel Lens 
Trial - Ml/OR 
Bar· From· (2) To· ( <) Count · Percent· .
1 1 2 18 51.429 -Mode 
2 2 3 16 45.714 
3 3 4 1 2.857 
4 4 5 0 0 
5 5 6 0 0 
Renk Frequency for System 1 o 
System 10- M1/0R 
Bar · From· (.~) To·(<) Count· Percent· 
1 1 2 15 41.667 
2 2 3 17 47.222 - Mode 
3 3 4 0 0 
4 4 5 4 11 . 111 
5 5 6 0 0 
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APPENDIX 7 
Over Refraction Significance and Rank Frequency of Month 3 
'tt'ilcoxon signed-ranlc Trial - M3/0R System 10- M3/0R 
Number: }; Rank : Mean Rank: 
:~:~~: ~~:~2=============~1:~~~9============~1~=0~.=75~=========~ 
note 15 cases eliminated for difference = 0. 
z -1 .894 p = .0582 
Z corrected for ties -1 .983 p = .0473 
# tied 9roups 3 
Note : 4 cases deleted w1th m1ssm9 values. 
Renk Frequency for the Triel Lens 
Trial- M3/0R 
Bar· From· (2) To· ( <) Count· Percent· 1 1 2 20 60.606~ -Mode 
2 2 3 13 39.394~ 
3 3 4 0 0~ 
4 4 5 0 0~ 
5 5 6 0 0~ 
Renk Frequency for System 10 
System 10- M3/0R 
Bar · From · (2) To · ( <) Count · Percent· 
1 1 2 17 51.515~ -Mode 
2 2 3 9 27.273~ 3 3 4 3 9.091~ 
4 4 5 4 12 . 121~ 5 5 6 0 0% 
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APPENDIX 8 
Edge/Blend Frequency and Chi Square 
Tr;a l-EDGES /BLENDS 
Bar: Ele-ment : Count : Percent: 
I ~2-1 --+~~-~-s----------~~~~-:------------+~~-~-:-:~----------~1-Mode 
Bar: Element : 
1: ~~~s 
DF: 
T ota 1 Chi-Square: 
G Statistic : 
Contingen~y Coefficient : 
Phi: 
System-EDGES/BLENDS 
Couni:: Percent: 
1:~ 140.541 59.459 
Chi Squere 
Contingency Table Analysis 
Summary Statistics: 
1 
.949 
.952 
.113 
.113 
Chi-Square with continuity correction : .534 
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APPENDIX 9 
Comfort Significance and Rank Frequency at Week 1 
Yilcoxon signed-rank Trial- Y1/C System 10- Y1/C 
Number : I Rank : Mean Rank : 
-Ranks ~1_7 _______ t1_6_4:...;..5 ______ t9:......._67_6 ____ --l 
+R~~ 1 65 65 ~------~~------~~-----~ 
note 19 cases eliminated for difference= 0 . 
2: -3.44 p = .0006 
Z corrected for ties -3.573 p = .0004 
# tied groups 2 
Renk Frequency for the Triel Lens 
Bar· From · (.~) 
1 1 
2 2 
3 3 
4 4 
5 5 
Bar: Fro~· (.i) 
1 1 
2 2 
3 3 
4 4 
5 5 
To· ( <) 
2 
3 
4 
5 
6 
Trial- Yl/C 
Count· 
9 
19 
8 
1 
0 
Renk Frequency for System 10 
System 10 - Y1/C 
To · ( <) Count · 
2 4 
3 14 
4 10 
5 9 
6 0 
37 
Percent· 
24.324 
51.351 
21.622 
2.703 
0 
Pt-rcent · 
1 0 .811 
37 .838 
27.027 
24.324 
0 
-Mode 
-Mode 
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APPENDIX 10 
Comfort Significance and Rank Frequency at Month 1 
Yilcoxon signed-rank Trial- Ml/C System 10 - Ml/C 
Number : I Rank : Mean Rank: 
-Ranks ~9 ______________ t6_5_.s ____________ t7_.2_7_8 __________ ~ 
+Ranks 5 39.5 7.9 ~------------~--------------~------------~ 
note 21 cases eliminated for difference= 0. 
z -.816 p = .4144 
Z corrected for ties -.881 p = .3785 
= tied groups 2 
Note : 2 cases deleted w1th m1ssmg values. 
Renk Frequency for the Tri el Lens 
Bar· From · (~) To· ( <) 
Trial - M1/C 
Count· Percent· 
1 1 2 7 20 
2 2 3 23 65.714 
3 3 4 3 8.571 
4 4 5 1 2.857 
5 5 6 1 2.857 
Rt:mk Frequency for System 1 0 
System 10- Ml/C 
Bar· From· (2:) To ·( <) Count· Percent· 
1 1 2 7 19.444 
2 2 3 19 52.778 
3 3 4 8 22.222 
4 4 5 1 2.778 
5 5 6 1 2 .778 
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APPENDIX 11 
Comfort Significance and Rank Frequency at Month 3 
'tt'ilcoxon signed-rank Trial- M3/C System 10-
Number: I Rank: Mean Rank: 
-Ranks 19 
+Ranks 3 ~~~ 1~·333 
note 21 cases elimina-ted for difference= 0. 
z -1 .412 p = .1579 
Z corrected for ties -1 .485 p = .1376 
st tied 9roups 2 
Note-: 4 cases deleted w1th m1ssmg values. 
Bar · From · (2) 
1 1 
2 2 
3 3 
4 4 
5 5 
Bar· From · (2) 
1 1 
2 2 
3 3 
4 4 
5 5 
Rank Frequency for the Trial Lens 
To· ( <) 
2 
3 
4 
5 
6 
Trial- M3/C 
Count· 
16 
16 
0 
1 
0 
Pe-rcent· 
48.485 
48.485 
0 
3.03 
0 
Rank Frequency for System 1 o 
System 10- M3/C 
To·(<) Count· Percent· 
2 12 36.364 
3 17 51 .51 s 
4 3 9.091 
5 1 3.03 
6 0 0 
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APPENDIX 12 
Outcome Significance and Rank Frequency at Week 1 
Yilcoxon signed-rank Trial - Y 1 /OUT System 1 0 - Y 1 /0 ... 
Number: I Rank : Mean Rani<: 
not~ 22 cases ~liminated for difference = 0. 
z -2.385 p = .0171 
Z corrected for ti~s -2.499 p = .0124 
# ti~d groups 2 
Renk Frequency for the Triel Lens 
Trial - Yt /OUT 
Bar· From · (.~) To · (<) Count· Percent· 
1 1 2 17 45.946 -Mode 
2 2 3 5 13.514 
3 3 4 9 24.324 
4 4 5 5 13.514 
5 5 r 1 2.703 0 
Renk Frequency for System 10 
System 10 - Yl/OUT 
-
Bar· From· (2) To·(<) Count· Percent· 
1 1 2 13 35.135 
2 2 3 6 16.216 
3 3 4 3 8 .108 
4 4 5 14 37.838 -Mode 
5 5 6 1 2.703 
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APPENDIX 13 
Outcome Significance and Rank Frequency at Month 1 
Yilcoxon signed-rank Trial - H1/0UT System 10 - H1/0 ... 
Number: ! Rank : Mean Rank : 
- Ranks ~1:...:3:..._ _____ t
7
.:....:1 ::;.:o:..._ ____ t9:...:·=2;;..3..:...1 ----~1 
+Ranks ~-4-------~-~-~------~-8_.~2_5 _____ ~; 
note- 1 8 cast>s e liminatt>d for difference- = 0. 
2 -2.059 p = .0395 
Z corrected for ties -2 .101 p = .0356 
= tied groups 3 
Note : 2 cases deleted w1th m1ssmg values. 
Renk Frequency for the Triel Lens 
Trial - H1/0UT 
Bar · From · (~) To · ( <) Count · Percent · 
1 1 2 17 48 .571 -Mode 
2 2 3 8 22.857 
3 3 4 6 17.143 
4 4 5 2 5.714 
5 5 6 2 5.714 
Renk Frequency for System 1 0 
System 10- H1/0UT 
Bar· From· (2) To · ( <) Count · Percent· 
1 1 2 11 30 .556 -Mode 
2 2 3 9 25 
3 3 4 6 16.667 
4 4 5 7 19.444 
5 5 6 3 8.333 
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APPENDIX 14 
Outcome Significance and Rank Frequency at Month 3 
'lr'ilcoxon signed-rank Trial- H3/0UT System 10 - M3/0 ... 
Number : l: Rank : Mean Rank : 
: ~:~~:1 ~ :~2=============~' ~=~=============~! ~=~=66=7==========~ 
note 20 cases eliminated for difference = 0. 
z -2.411 p = .0159 
Z corrected for ties -2.444 p = .0145 
• tied groups 3 
Note: 4 cases deleted w1th m1ssmq values. 
Renk Frequency for the Trial Lens 
Trial- M3/0UT 
Bar · From · (.~) To·(<) Count· Percent· 
1 1 2 13 39.394 -Mode 
2 2 3 12 36.364 
3 3 4 7 21 .212 
4 4 5 1 3.03 
5 5 6 0 0 
Renk Frequency for System 1 0 
System 1 0 - M3/0UT 
Bar· From· (2) To·(<) Count· Percent· 
1 1 2 a 24.242 
2 2 3 10 30.303 -Mode 
3 3 4 7 21.212 
4 4 5 7 21 .212 
5 5 6 1 3.03 
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APPENDIX 15 
Overall Outcome Significance and Rank Frequency 
Wilcoxon signed-r-ank Tr-ial-Outcome Stjstem 1 0-0utcome 
Number : I Rank : Mean Rank : 
: ::~~: ~I :~3============~l=~=~============~l ~~~2~3~1=========~ 
no~e 23 cases eliminated for difference = 0 . 
z -2.605 p = .0092 
Z corrected for ties -2.634 p = .0084 
# tied groups 3 
Rank Frequency for the Trial Lens 
Tr-ial-Over-all Outcome 
Bar· From· (~) To· ( <) Count· Percent· 
1 1 2 14 37.838 -Mode 
2 2 ' 3 12 32.432 
3 3 4 7 18.919 
4 4 s 1 2.703 
s s 6 3 8.108 
Renk Frequency for System 1 0 
SQstem 1 0-0ver-all Outcome 
Bar · From · (2) To· ( <) Count· Percent· 
1 1 2 8 21.622 
2 2 3 10 27.027 -Mode 
3 3 4 7 18.919 
4 4 s 7 18.919 
5 5 6 5 13.514 
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APPENDIX 16 
LENS CHANGES INDICATED BY GRADING 
SCALES 
DIAMETER 
INCREASED 
POWER 
B.C.& DIAMETER 
TRIAL FIT 
3 
(9.3 TO 9.65) 
(9.6 TO 9.9) 
(9.3 TO 9.6) 
0 
0 
44 
SYSTEM 10 
FIT 
2 
(9.1 TO 9.6) 
(9.5 TO 9.9) 
2 
(O.R. +1.00) 
(O.R. +.50) 
1 
(7 .63 TO 7.55 
&8.65 TO 8.8) 
